0001209191-23-050223.txt : 20230920
0001209191-23-050223.hdr.sgml : 20230920
20230920200930
ACCESSION NUMBER: 0001209191-23-050223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230918
FILED AS OF DATE: 20230920
DATE AS OF CHANGE: 20230920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Curet Myriam
CENTRAL INDEX KEY: 0001632901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 231267579
BUSINESS ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
BUSINESS PHONE: 408-523-7587
MAIL ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
FORMER NAME:
FORMER CONFORMED NAME: Myriam Curet
DATE OF NAME CHANGE: 20150205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-18
0
0000906709
NEKTAR THERAPEUTICS
NKTR
0001632901
Curet Myriam
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BLVD SOUTH, SUITE 100
SAN FRANCISCO
CA
94158
1
0
0
0
0
Common Stock
2023-09-18
4
S
0
4359
0.69
D
27418
D
Stock Option
0.68
2023-09-19
4
A
0
85000
0.00
A
2031-09-18
Common Stock
85000
85000
D
Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction.
This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.
Mark A. Wilson, Attorney-in-Fact
2023-09-20